The global Gingivitis Treatment Market is expected to garner a market value of USD 7 Billion in 2023 and is expected to accumulate a market value of USD 11.19 Billion by registering a CAGR of 4.8% in the forecast period 2023 to 2033. The market for Gingivitis Treatment registered a CAGR of 3.2% in the historical period 2018 to 2022.
The gingivitis treatment market refers to the global market for products and services used to treat gingivitis, which is a common gum disease caused by inflammation of the gum tissue surrounding the teeth.
The market for gingivitis treatment is expected to grow significantly over the next few years due to the increasing prevalence of gum disease, rising awareness about oral health, and the introduction of innovative products and technologies for gingivitis treatment.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2023) | USD 7 Billion |
| Anticipated Forecast Value (2033) | USD 11.19 Billion |
| Projected Growth Rate (2023 to 2033) | 4.8% CAGR |
Explore FMI!
Book a free demo
According to market research and competitive intelligence provider, Future Market Insights- the market for Gingivitis Treatment reflected a value of 3.2% during the historical period, 2018 to 2022. There has been a growing awareness about the importance of oral health in recent years. Consumers are becoming more conscious of the link between oral health and overall health, leading to increased demand for oral care products and services. This trend is driving growth in the gingivitis treatment market as consumers seek out effective solutions for gum disease.
Furthermore, the rise of e-commerce and online sales channels is also driving growth in the gingivitis treatment market. Consumers are increasingly turning to online channels to purchase oral care products and services, which is creating new opportunities for companies operating in the market.
Overall, the market for Gingivitis Treatment is expected to register a CAGR of 4.8% in the forecast period 2023 to 2033.
Increasing Prevalence of Gingivitis to push market growth
One of the major factors driving growth in the gingivitis treatment market is the increasing prevalence of gum disease. According to the Centers for Disease Control and Prevention (CDC), nearly half of all adults in the United States have some form of gum disease. Similar trends are observed in other regions around the world, driving demand for effective treatment options.
Gingivitis is a common form of gum disease that causes inflammation and bleeding of the gums, and if left untreated, it can progress to more severe forms of gum disease. According to the World Health Organization, gingivitis is one of the most prevalent oral health issues worldwide, affecting up to 90% of the global population at some point in their lives.
The rising prevalence of gingivitis can be attributed to several factors, including poor oral hygiene, smoking, aging, and certain medical conditions that affect oral health. As the prevalence of gingivitis continues to increase, there is a growing demand for effective treatment options, which is expected to drive the growth of the gingivitis treatment market.
Furthermore, as the awareness of the link between oral health and overall health continues to grow, more people are seeking out treatment options for gingivitis to maintain good oral health and prevent other health issues. This is expected to further drive the growth of the gingivitis treatment market.
Overall, the increasing prevalence of gingivitis is expected to push the growth of the gingivitis treatment market, presenting opportunities for companies operating in the market to expand their offerings and capture market share.
In addition, the introduction of innovative products and technologies for gingivitis treatment is driving growth in the market. For example, the use of lasers for gum disease treatment has gained popularity in recent years due to its effectiveness and minimally invasive nature. Similarly, the development of new formulations and delivery mechanisms for oral care products is driving demand for these products.
Expensive Cost of Treatment to restrict Market Growth
Despite the growing awareness of the importance of maintaining good oral health, many people still lack awareness of gum disease and its treatment options. This can limit demand for gingivitis treatment products and services.
Additionally, the cost of gingivitis treatment can be a barrier for many people, particularly those without insurance coverage. This can limit demand for treatment options and make it more challenging for companies to generate revenue..
Companies operating in the gingivitis treatment market must comply with regulatory requirements related to product safety and efficacy. This can be challenging and costly, particularly for smaller companies without significant resources. Overall, companies operating in the gingivitis treatment market must navigate these challenges to capture market share and drive growth. By developing innovative products, building strong brands, and effectively communicating the benefits of their offerings, companies can overcome these challenges and succeed in this market.
Increasing awareness and diagnosis of the condition Shaping Landscape for Gingivitis Treatment in South & East Asia
The gingivitis treatment market in the South and East Asia region is growing rapidly due to several factors, including increasing awareness of oral health, rising disposable incomes, and the presence of a large population base.
Countries like China, India, Japan, and South Korea are some of the key markets for gingivitis treatment products in the region. These countries have a large population base, and a significant percentage of the population suffers from gum disease. As a result, there is a high demand for gingivitis treatment products in these markets.
In addition, increasing disposable incomes and growing awareness of the importance of oral health are driving demand for high-quality oral care products, including those used for gingivitis treatment. This has led to the introduction of new products and technologies in the market, including innovative toothpaste formulations, mouthwashes, and advanced dental instruments.
Overall, the gingivitis treatment market in the South and East Asia region is expected to continue to grow in the coming years, driven by increasing demand for oral care products and rising awareness of the importance of oral health.
Increasing Focus on Technological advancements Shaping Landscape for Gingivitis Treatment in North America
There is a growing awareness of the importance of oral health in North America, which is driving demand for gingivitis treatment products. People are becoming more aware of the links between gum disease and overall health, which is encouraging them to take better care of their teeth and gums.
There have been significant technological advances in gingivitis treatment products, including new toothpaste formulations, advanced dental instruments, and innovative oral care products. Dental insurance is widely available in North America, which makes it easier for people to access gingivitis treatment products and services. This is driving demand for these products and services, as people are more likely to seek treatment when they have insurance coverage.
Oral route of administration to hold a significant share and push market growth
The oral route of administration is likely to account for a significant share in the gingivitis treatment market. Oral gingivitis treatment products include tablets, capsules, and liquid formulations, which are ingested by patients to treat the condition. These products are convenient to use and offer systemic treatment, which can help to address the underlying causes of gum disease.
In addition, many oral gingivitis treatment products are available over-the-counter, which makes them easily accessible to patients. This convenience and accessibility are expected to drive demand for oral gingivitis treatment products in the market.
Retail pharmacies segment to hold a significant share and push market growth
The retail pharmacy segment is likely to account for a significant share in the gingivitis treatment market by distribution channel. Retail pharmacies are easily accessible to patients and offer a wide range of gingivitis treatment products, including over-the-counter and prescription medications. Patients can receive expert advice from pharmacists on the use of these products and their effectiveness in treating gum disease.
In addition, retail pharmacies offer the convenience of online ordering and home delivery, which has become increasingly popular in recent years. This convenience and accessibility are expected to drive demand for gingivitis treatment products through retail pharmacies.
Key players in the market include companies such as Fibrocell Sciences, Tolmar Inc., Eli Lilly & Company, Align Technology, Dentsply International, 3M Company, Ultradent Products Inc., Nobel Biocare Holdings AG, Glidewell Laboratories, Orapharma, Kaken Pharmaceutical, and Valeant Pharmaceuticals Int., along with healthcare providers and technology companies among other global players.
The technique involves a specialized probe and detector that provide quantitative measurements of biomarkers indicating the presence and severity of gum disease. These biomarkers were validated and identified by the university's Periodontal Research Group and published in the Journal of Clinical Periodontology earlier this year. The researchers have secured funding from the EPSRC Impact Acceleration Account to create a prototype of the device, which is expected to be launched within a year.
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | USD 7 Billion |
| Market Value in 2033 | USD 11.19 Billion |
| Growth Rate | CAGR of 4.8% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD Million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Route of Administration, End-User, Drug Class, Region |
| Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Rest of Latin America, Germany, United Kingdom, France, Spain, Italy, Rest of Europe, Malaysia, Singapore, China, India, Thailand, Rest of South Asia, Gulf Cooperation Council, Japan, South Korea, Australia, New Zealand, GCC countries, South Africa, Israel, Rest of MEA |
| Key Companies Profiled | Fibrocell Sciences; Tolmar Inc.; Eli Lilly & Company; Align Technology; Dentsply International; 3M Company; Ultradent Products Inc.; Nobel Biocare Holdings AG; Glidewell Laboratories; Orapharma; Kaken Pharmaceutical; and Valeant Pharmaceuticals Int. |
| Customization | Available Upon Request |
The market is estimated to secure a valuation of USD 7 billion in 2023.
The market is estimated to reach USD 11.19 billion by 2033.
Retail pharmacy sector holds high revenue potential.
The United States, India, and China dominate the global market.
The market is forecast to register a CAGR of 4.8% through 2033.
Home Respiratory Therapy Market – Growth & Forecast 2025 to 2035
Home Infusion Therapy Devices Market - Growth & Forecast 2025 to 2035
Human Combinatorial Antibody Libraries (HuCAL) Market - Trends & Forecast 2025 to 2035
Home Healthcare Market Growth - Trends, Innovations & Forecast 2025 to 2035
Dental 3D Printing Material Market Trends, Growth & Forecast by Material, Product, and Region through 2035
Catheter Market Insights by Product, Indication, End-user, and Region 2025 to 2035
Gingivitis Treatment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
